Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,729.03
(
0.44%
)
US TECH 100
24,202.80
(
0.78%
)
Dow Jones
47,133.12
(
0.40%
)
Brent Oil
99.22
(
0.93%
)
Bitcoin
74,201.61
(
-0.86%
)
News Focus
News Focus
Post# of 257251
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122790
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 118089

Wednesday, 05/25/2011 11:02:18 AM

Wednesday, May 25, 2011 11:02:18 AM

Post# of 257251
Yet another branded-generics deal—WPI acquires Specifar Pharma for $560M in cash:

http://finance.yahoo.com/news/Watson-Acquires-Specifar-prnews-2159758683.html?x=0&.v=1

The Specifar group is in the top five in the Greek branded-generic market, with a portfolio of more than 30 products, including internally developed and in-licensed products sold through a sales force of 170 employees. Specifar also markets products in Greece under the Alet Pharmaceuticals brand through a separate 55 representative sales force.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now